Pre-Transplant Multiparameter Flow Cytometric Measurable Residual Disease in Acute Myeloid Leukemia As an Independent Prognostic Factor for Survival after Myeloablative Allogeneic Hematopoietic Cell Transplantation
Anna Czyż(Wroclaw Medical University), Agnieszka Wierzbowska(Medical University of Lodz), Jan Maciej Zaucha(Gdańsk Medical University), Tomasz Czerw(The Maria Sklodowska-Curie National Research Institute of Oncology), Agnieszka Pluta, Gail J. Roboz(Cornell University), Barbara Nasiłowska‐Adamska, Anna Kopińska(Medical University of Silesia), Małgorzata Sobczyk‐Kruszelnicka(The Maria Sklodowska-Curie National Research Institute of Oncology), Agnieszka Piekarska(Gdańsk Medical University), Tomasz Wróbel, Jolanta Parulska(Poznan University of Medical Sciences), Marta Sobas, Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Andi Rustani(NewYork–Presbyterian Hospital), Michael S. Samuel(Cancer Research UK Scotland Institute), Nuria Mencia Trinchant(NewYork–Presbyterian Hospital), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Patrycja Mensah‐Glanowska(Jagiellonian University), Lidia Gil(Poznan University of Medical Sciences), Maria Bieniaszewska(Gdańsk Medical University), Grzegorz Helbig(Medical University of Silesia), Elżbieta Patkowska(Institute for Transfusion Medicine), Magdalena Dutka(Gdańsk Medical University), Andrzej Szczepaniak(Poznan University of Medical Sciences), Maciej Majcherek(Wroclaw Medical University), Pinkal Desai(Cornell University), Jolanta Woźniak(Instytut Hematologii i Transfuzjologi), Justin D. Kaner(NewYork–Presbyterian Hospital), Sylwia Bartyzel-Palińska(Jagiellonian University), Ellen K. Ritchie(Cornell University), Agnieszka Balana(Jagiellonian University), Donata Szymczak(Wrocław University of Science and Technology), Kazimierz Hałaburda(Poznan University of Medical Sciences), Agnieszka Tomaszewska(Medical University of Warsaw), Ameenah Sukkur(NewYork–Presbyterian Hospital)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k